Went to EDAP website and typed in FDA approval in the search engine. A story popped saying "EDAP has just received FDA approval" for its Sonolith I-sys lithotripter. It said the devise is cleared for routine ESWL treatment.
Question to EDAP mavens: is this something new or a recycled story?
Could be the case but I would think they would pull them after some filled if they were testing to see if they could get some filled??? That's a lot of shares for a stock that can be very thinly traded. And there's that 24k on the ask at 4.30 again.